PULSE BIOSCIENCES, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pulse Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q3 2024.
  • Pulse Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.98M, a 65.9% increase year-over-year.
  • Pulse Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $10.1M, a 121% increase year-over-year.
  • Pulse Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.18M, a 38.3% increase from 2022.
  • Pulse Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.19M, a 64.4% decline from 2021.
  • Pulse Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $14.6M, a 44.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $10.1M $2.98M +$1.18M +65.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $8.95M $2.05M +$909K +79.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $8.04M $1.76M +$863K +96.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $7.18M $3.34M +$2.6M +347% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $4.59M $1.8M +$1.08M +149% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $3.51M $1.14M -$570K -33.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $4.08M $896K -$1.11M -55.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $5.19M $748K -$2.86M -79.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $8.05M $723K -$854K -54.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $8.91M $1.71M -$735K -30% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $9.64M $2.01M -$4.96M -71.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $14.6M $3.61M +$1.22M +51.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $13.4M $1.58M -$1.07M -40.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $14.5M $2.45M +$36K +1.49% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $14.4M $6.97M +$4.34M +165% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $10.1M $2.39M -$1.16M -32.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 $11.2M $2.65M -$30K -1.12% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $11.3M $2.41M -$287K -10.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $11.6M $2.63M +$265K +11.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $11.3M $3.55M +$1.2M +51% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 $10.1M $2.68M -$714K -21% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $10.8M $2.7M -$476K -15% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $11.3M $2.36M -$1.06M -31% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $12.3M $2.35M -$2.17M -48% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $14.5M $3.39M +$43K +1.28% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $14.5M $3.18M +$385K +13.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $14.1M $3.42M +$3.16M +1200% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $10.9M $4.52M +$4.28M +1761% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $6.65M $3.35M +$3.11M +1308% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $3.53M $2.79M +$2.59M +1323% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $940K $263K +$70K +36.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $870K $243K +$107K +78.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 $763K $238K +$133K +127% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $630K $196K +$89K +83.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $541K $193K +$139K +257% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $402K $136K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $105K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $107K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $54K Jan 1, 2015 Mar 31, 2015 10-Q 2016-06-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.